Filing Details

Accession Number:
0001209191-17-034536
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-22 21:56:03
Reporting Period:
2017-02-27
Filing Date:
2017-05-22
Accepted Time:
2017-05-22 21:56:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1266806 Second Sight Medical Products Inc EYES Electromedical & Electrotherapeutic Apparatus (3845) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1678706 Trust Living Mann E. Alfred 12744 San Fernando Road
Sylmar CA 91342
No No Yes No
1678708 Incumed, Llc 12744 San Fernando Road
Sylmar CA 91342
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-02-27 40,591 $1.68 2,226,145 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-02-28 39,028 $1.65 2,187,117 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-03-01 44,126 $1.62 2,142,991 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-03-02 55,824 $1.53 2,087,167 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-03-03 21,715 $1.53 2,065,452 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-03-06 113,359 $1.43 1,952,093 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-03-07 94,084 $1.48 1,858,009 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-03-08 182,917 $1.69 1,675,092 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-03-09 105,865 $1.57 1,569,227 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-03-10 118,740 $1.38 1,450,487 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-03-13 23,916 $1.38 1,426,571 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-04-07 1,426,571 $1.00 0 No 4 S Indirect By Incumed, LLC
Common Stock Disposition 2017-04-07 5,218,420 $1.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Indirect By Incumed, LLC
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants to Purchase Common Stock Disposition 2017-04-07 80,000 $0.00 80,000 $5.00
Common Stock Warrants to Purchase Common Stock Disposition 2017-04-07 280,000 $0.00 280,000 $5.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2012-07-31 2017-07-31 No 4 S Direct
0 2013-02-23 2018-02-28 No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 14, 2016.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.62 to $1.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  3. The Alfred E. Mann Living Trust is the sole manager and member of Incumed, LLC.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.61 to $1.69, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.59 to $1.68, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.50 to $1.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  7. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.56, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.38 to $1.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.40 to $1.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.53 to $1.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  11. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.48 to $1.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  12. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.32 to $1.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  13. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.35 to $1.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
  14. Private sale to group of individual accredited private investors.